C4X DISCOVERY LIMITED

Organization

MANCHESTER, GB

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Therapeutic compounds
- Patent number 12,098,148
- Issue date Sep 24, 2024
- C4X Discovery Limited
- Emma L. Blaney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds as inhibitors of the orexin-1 receptor
- Patent number 12,024,509
- Issue date Jul 2, 2024
- C4X Discovery Limited
- Emma Louise Blaney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds
- Patent number 11,753,398
- Issue date Sep 12, 2023
- C4X Discovery Limited
- Barrie P. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds
- Patent number 11,130,746
- Issue date Sep 28, 2021
- C4X Discovery Limited
- Barrie P. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds
- Patent number 10,696,654
- Issue date Jun 30, 2020
- C4X Discovery Limited
- Barrie Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds as inhibitors of the orexin-1 receptor
- Patent number 10,611,760
- Issue date Apr 7, 2020
- C4X Discovery Limited
- Emma Louise Blaney
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
THERAPEUTIC COMPOUNDS
- Publication number 20250084075
- Publication date Mar 13, 2025
- C4X Discovery Limited
- Emma Louise Blaney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAHYDROISOQUINOLINE COMPOUNDS THAT ARE KEAP1 BINDERS.
- Publication number 20240424112
- Publication date Dec 26, 2024
- C4X Discovery Limited
- Catherine Louise Lucas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC COMPOUNDS
- Publication number 20240076282
- Publication date Mar 7, 2024
- C4X Discovery Limited
- Barrie Phillip Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS
- Publication number 20230167084
- Publication date Jun 1, 2023
- C4X Discovery Limited
- Cathy Louise Lucas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS
- Publication number 20230159511
- Publication date May 25, 2023
- C4X Discovery Limited
- Cathy Louise Lucas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOUNDS
- Publication number 20220002286
- Publication date Jan 6, 2022
- C4X Discovery Limited
- Emma L. Blaney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOUNDS
- Publication number 20200255404
- Publication date Aug 13, 2020
- C4X Discovery Limited
- Barrie P. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOUNDS
- Publication number 20190040041
- Publication date Feb 7, 2019
- C4X Discovery Limited
- Barrie P. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR DETERMINING THREE-DIMENSIONAL STRUCTURES OF DYNAMIC MOLE...
- Publication number 20180096112
- Publication date Apr 5, 2018
- C4X Discovery Limited
- Charles Douglas Blundell
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
THERAPEUTIC COMPOUNDS AS INHIBITORS OF THE OREXIN-1 RECEPTOR
- Publication number 20170291897
- Publication date Oct 12, 2017
- C4X Discovery Limited
- Emma Louise Blaney
- C07 - ORGANIC CHEMISTRY

NIH Research Projectlast 12 months

processing...

Count: 1

Research Projects

Information Research Project
Preclinical development of a selective Orexin-1 receptor antagonist...
- Application id 9460149
- Award notice date Jun 29, 2018

C4X DISCOVERY LIMITED

Organization

Patents Grantslast 30 patents

Therapeutic compounds

Therapeutic compounds as inhibitors of the orexin-1 receptor

Therapeutic compounds

Therapeutic compounds

Therapeutic compounds

Therapeutic compounds as inhibitors of the orexin-1 receptor

Patents Applicationslast 30 patents

THERAPEUTIC COMPOUNDS

TETRAHYDROISOQUINOLINE COMPOUNDS THAT ARE KEAP1 BINDERS.

THERAPEUTIC COMPOUNDS

TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS

TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS

THERAPEUTIC COMPOUNDS

THERAPEUTIC COMPOUNDS

THERAPEUTIC COMPOUNDS

METHOD FOR DETERMINING THREE-DIMENSIONAL STRUCTURES OF DYNAMIC MOLE...

THERAPEUTIC COMPOUNDS AS INHIBITORS OF THE OREXIN-1 RECEPTOR

NIH Research Projectlast 12 months

Research Projects

Preclinical development of a selective Orexin-1 receptor antagonist...